Marketing-authorisation holder · Netherlands
Kite Pharma Eu B.V.
8 medicines in 4 countries, as authorisation holder.
Group structure
Part of
KITEPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
8 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| TECARTUSDispersione per infusione | Brexucabtagene autoleucel | Italy | Authorised | |
| Tecartus | Brexucabtagene autoleucel | EU (EMA) | Authorised | 2020 |
| Tecartus 0.4-2.0 x 10^8 cellen, dispersie voor infusieOplossing voor infusie | Brexucabtagene autoleucel | Netherlands | Authorised | 2020 |
| TECARTUS 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION1 × 10e6 a 2 x 10e6 CELULAS · Dispersion para perfusion | Brexucabtagene autoleucel | Spain | Marketed | 2020 |
| Yescarta | Axicabtagene ciloleucel | EU (EMA) | Authorised | 2018 |
| YESCARTADispersione per infusione | Axicabtagene ciloleucel | Italy | Authorised | |
| YESCARTA 0,4 - 2 x 10e8 CELULAS DISPERSION PARA PERFUSION2 x 10e8 CELULAS · Dispersion para perfusion | Axicabtagene ciloleucel | Spain | Marketed | 2018 |
| Yescarta, maximum of 2 x 108 cells/68 ml dispersie voor infusieOplossing voor infusie | Axicabtagene ciloleucel | Netherlands | Authorised | 2018 |